These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 36189341)

  • 1. Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases?
    Scariot DB; Staneviciute A; Zhu J; Li X; Scott EA; Engman DM
    Front Cell Infect Microbiol; 2022; 12():1000972. PubMed ID: 36189341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavonoids as efficient scaffolds: Recent trends for malaria, leishmaniasis, Chagas disease, and dengue.
    Boniface PK; Ferreira EI
    Phytother Res; 2019 Oct; 33(10):2473-2517. PubMed ID: 31441148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis.
    Alcântara LM; Ferreira TCS; Gadelha FR; Miguel DC
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):430-439. PubMed ID: 30293058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The translational challenge in Chagas disease drug development.
    Kratz JM; Gonçalves KR; Romera LM; Moraes CB; Bittencourt-Cunha P; Schenkman S; Chatelain E; Sosa-Estani S
    Mem Inst Oswaldo Cruz; 2022; 117():e200501. PubMed ID: 35613156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecules containing chalcogen elements (S, Se, Te) as new warhead to fight neglected tropical diseases.
    Henriquez-Figuereo A; Morán-Serradilla C; Angulo-Elizari E; Sanmartín C; Plano D
    Eur J Med Chem; 2023 Jan; 246():115002. PubMed ID: 36493616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endophytic Fungi in the Fight Against Neglected Tropical Diseases.
    Costa MBS; de Oliveira CM
    Mini Rev Med Chem; 2020; 20(16):1683-1693. PubMed ID: 32579496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review.
    Santos SS; de Araújo RV; Giarolla J; Seoud OE; Ferreira EI
    Int J Antimicrob Agents; 2020 Apr; 55(4):105906. PubMed ID: 31987883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational Option.
    Sbaraglini ML; Vanrell MC; Bellera CL; Benaim G; Carrillo C; Talevi A; Romano PS
    Curr Top Med Chem; 2016; 16(19):2201-22. PubMed ID: 26881713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmanicidal and Trypanocidal Activity of Metal Complexes with 1,2,4-Triazolo[1,5-a]pyrimidines: Insights on their Therapeutic Potential against Leishmaniasis and Chagas Disease.
    Salas JM; Caballero AB; Esteban-Parra GM; Méndez-Arriaga JM
    Curr Med Chem; 2017; 24(25):2796-2806. PubMed ID: 28521698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
    Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
    Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological approaches to antitrypanosomal chemotherapy.
    Croft SL
    Mem Inst Oswaldo Cruz; 1999; 94(2):215-20. PubMed ID: 10224531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnological approaches against Chagas disease.
    Romero EL; Morilla MJ
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):576-88. PubMed ID: 19941920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent approaches in nanocarrier-based therapies for neglected tropical diseases.
    Mengarda AC; Iles B; Longo JPF; de Moraes J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1852. PubMed ID: 36161523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious diseases. Drug developers finally take aim at a neglected disease.
    Leslie M
    Science; 2011 Aug; 333(6045):933-5. PubMed ID: 21852468
    [No Abstract]   [Full Text] [Related]  

  • 15. Chagas Disease: A Solvable Problem, Ignored.
    Tarleton RL
    Trends Mol Med; 2016 Oct; 22(10):835-838. PubMed ID: 27523778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
    Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
    J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Rationale for Use of Amiodarone and its Derivatives for the Treatment of Chagas' Disease and Leishmaniasis.
    Benaim G; Paniz-Mondolfi AE; Sordillo EM
    Curr Pharm Des; 2021; 27(15):1825-1833. PubMed ID: 32988342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of E1224 by leveraging a strategic partnership for the medicines creation against neglected tropical diseases.
    Hata K
    Parasitol Int; 2021 Apr; 81():102278. PubMed ID: 33370607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate-Based Molecules as Potential New Antiparasitic Drugs.
    Branco Santos JC; de Melo JA; Maheshwari S; de Medeiros WMTQ; de Freitas Oliveira JW; Moreno CJ; Mario Amzel L; Gabelli SB; Sousa Silva M
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32503272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parasite prolyl oligopeptidases and the challenge of designing chemotherapeuticals for Chagas disease, leishmaniasis and African trypanosomiasis.
    Bastos IM; Motta FN; Grellier P; Santana JM
    Curr Med Chem; 2013; 20(25):3103-15. PubMed ID: 23514419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.